432 of 500
Actavis
Financials: Latest Results
Rank: 432
Previous rank: 515
CEO: Paul M. Bisaro
Headquarters:
400 Interpace Pkwy.
Parsippany, NJ. 07054
862-261-7000
Website: www.actavis.com
Network with Actavis
Key financials
$ millions
% change from 2011
Revenues
5,914.9
29
Profits
97.3
-62.7
Assets
14,103.5
Stockholder's equity
3,833.8
Market cap (on 3/29/2013)
11,774.6
Profits as % of
Revenues
1.6
Assets
0.7
Stockholders' equity
2.5
Earnings per share
2012$
0.76
% change from 2011
-63.1
2002-2012 annual growth rate %
-7.4
Total return to investors
%
2012
42.5
2002-2012 annual rate
11.8
From the May 20, 2013 issue

Notes:
Changed name from Watson Pharmaceuticals, Jan. 24, 2013.
What do you think of Actavis?
Companies are ranked by total revenues for their respective fiscal years. Included in the survey are companies that are incorporated in the U.S. and operate in the U.S. and file financial statements with a government agency. More
Current Issue
  • Give the gift of Fortune
  • Get the Fortune app
  • Subscribe
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.